SEC Form 4 · accession 0001213900-26-091211
NewGenIvf Group Ltd · NIVF
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Hei Yue Tina Fong
Officer — Chief Marketing Officer · Director
Period of report
Aug 17, 2026
Accepted (ET)
Aug 18, 2026 · 4:01 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001981662
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy)F1 | $0.0001 | Aug 17, 2026 | A | 272,140 | A | — | Aug 17, 2033 | Class B Ordinary Shares | 272,140 | 345,787 | D |
Explanation of responses
- F1Reflects the grant of stock options to acquire 272,140 Class B Ordinary Shares of the Issuer at an exercise price of US$0.0001 per share, made pursuant to the Issuer's 2024 Share Incentive Plan and the Employee Stock Option Agreement, dated August 17, 2026, between the Issuer and the Reporting Person (the "Option Agreement"). The options vest upon grant and expire on August 17, 2033 (Grant Date + 7 years), subject to earlier termination as provided in the Option Agreement and the Plan.